Evidence map›Paper›PMID 31684863›Full record

ArticleBMC plant biology2019

Clarification of the dispensability of PDX1.2 for Arabidopsis viability using CRISPR/Cas9.

Elisa Dell'Aglio, Ivan Dalvit, Sylvain Loubéry, Teresa B Fitzpatrick

Abstract read
In one paragraph

Article in BMC plant biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elisa Dell'AglioDepartment of Botany and Plant Biology, University of Geneva, 1211, Geneva, Switzerland.
Ivan DalvitDepartment of Botany and Plant Biology, University of Geneva, 1211, Geneva, Switzerland.
Sylvain LoubéryDepartment of Botany and Plant Biology, University of Geneva, 1211, Geneva, Switzerland.
Teresa B FitzpatrickDepartment of Botany and Plant Biology, University of Geneva, 1211, Geneva, Switzerland. teresa.fitzpatrick@unige.ch.

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung PPOOA_1191186; 31003A-141117/1
6 · The paper itself

Abstract

backgroundPDX1.2 has recently been shown to be a regulator of vitamin B

resultsWe have studied the previously reported insertion alleles of PDX1.2, one of which is claimed to be essential for embryogenesis (pdx1.2-1), whereas the other is viable (pdx1.2-2). Our study shows that pdx1.2-1 carries multiple T-DNA insertions, but the T-DNA insertion in PDX1.2 is not responsible for the loss of embryogenesis. By contrast, the pdx1.2-2 allele is an overexpressor of PDX1.2 under standard growth conditions and not a null allele as previously reported. Nonetheless, upregulation of PDX1.2 expression under heat stress is impaired in this mutant line. In wild type Arabidopsis, studies of PDX1.2-YFP fusion proteins show that the protein is enhanced under heat stress conditions. To clarify if PDX1.2 is essential for Arabidopsis viability, we generated several independent mutant lines using the CRISPR-Cas9 gene editing technology. All of these lines are viable and behave similar to wild type under standard growth conditions. Reciprocal crosses of a subset of the CRISPR lines with pdx1.2-1 recovers viability of the latter line and demonstrates that knocking out the functionality of PDX1.2 does not impair embryogenesis.

conclusionsGene editing reveals that PDX1.2 is dispensable for Arabidopsis viability and resolves conflicting reports in the literature on its function.

Indexed as

CRISPR-Cas SystemsPhenotypeArabidopsisArabidopsis ProteinsBase SequenceGene Expression Regulation, PlantHot TemperatureLoss of Function MutationArabidopsis ProteinsPDX1.2 protein, ArabidopsisArabidopsis thalianaCRISPR-Cas9Heat shock elementHeat-stressMutant allelesPDX1.2T-DNA insertionViabilityVitamin B6

Identifiers

PMID31684863
PMCPMC6829848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.